Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.64 USD | +2.59% | +5.25% | -32.78% |
May. 09 | Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating | MT |
May. 09 | B. Riley Downgrades Viridian Therapeutics to Neutral From Buy | MT |
Financials (USD)
Sales 2024 * | 370K | Sales 2025 * | 330K | Capitalization | 934M |
---|---|---|---|---|---|
Net income 2024 * | -230M | Net income 2025 * | -266M | EV / Sales 2024 * | 1,273 x |
Net cash position 2024 * | 462M | Net cash position 2025 * | 625M | EV / Sales 2025 * | 935 x |
P/E ratio 2024 * |
-3.95
x | P/E ratio 2025 * |
-3.73
x | Employees | 94 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.26% |
Latest transcript on Viridian Therapeutics, Inc.
1 day | +2.59% | ||
1 week | +5.25% | ||
Current month | +10.41% | ||
1 month | -2.98% | ||
3 months | -21.25% | ||
6 months | -3.68% | ||
Current year | -32.78% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 23-10-29 |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 23-04-30 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 18-01-02 |
Tomas Kiselak
CHM | Chairman | 38 | 20-10-27 |
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 23-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 234 M€ | +6.34% | - | |
0.03% | 1,487 M€ | +9.08% | - | |
0.02% | 2 M€ | -.--% | ||
0.01% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 14.63 | +2.52% | 807,831 |
24-05-15 | 14.27 | -2.73% | 719,140 |
24-05-14 | 14.67 | +2.30% | 640,880 |
24-05-13 | 14.34 | +3.17% | 630,499 |
24-05-10 | 13.9 | -0.07% | 858,169 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.78% | 934M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- VRDN Stock